| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |